Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine In this Review, Alice Bernard-Tessier & @mishabeltran.bsky.social discuss the underlying biology in mHSPC and highlight current knowledge gaps: doi.org/10.1172/JCI2...
In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social www.sciencedirect.com/science/arti...
In Memory of Dr. Felix Feng
sciencedirect.com
I'm pleased to announce that the ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed and will fund a young prostate cancer investigator every year, in perpetuity. The First Felix Feng YIA recipient will be announced this spring and celebrated at ASCO's annual meeting.
SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals. Free registration and Hybrid option! In partnership with Servier and Medscape
Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social aacrjournals.org/clincancerre...
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Abstract. Lineage plasticity and histologic transformation from prostate adenocarcinoma to neuroendocrine prostate cancer (NEPC) occurs in up to 15-20% of patients with castration-resistant prostate c...
aacrjournals.org
